Image

Reported Experience Measurement on Reducing Patient Discomfort in Intensive Care

Reported Experience Measurement on Reducing Patient Discomfort in Intensive Care

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Hospitalisation in intensive care is always traumatic and can lead to a long rehabilitation process, slowed down by symptoms of anxiety and/or depression, and/or post-traumatic stress disorder (PTSD). These psychiatric disorders, or post-intensive care syndrome (PICS), can persist for several years after hospitalisation in intensive care and cause functional disability. They are associated with the use of psychotropic drugs and mental health services, and impair health-related quality of life.

This research is based on the hypothesis that the traumatic nature of intensive care hospitalisation can be reduced by implementing programmes to improve intensive care hospitalisation conditions, promoting changes in the practices of all healthcare professionals involved in intensive care.

IPREA3 study (Kalfon et al, 2017) demonstrated that implementation of a tailor-made, multi-component programme, led by a doctor/non-medical caregiver significantly reduced the overall discomfort score (derived from the IPREA questionnaire) perceived by patients hospitalised in an intensive care unit with sufficient experience in applying this programme, having used it for at least 5 months (Kalfon et al, 2017) .

The originality and interest of this research, in comparison with the IPREA3 study, lie in the following aspects:

  • the use of the most recent version of the IPREA questionnaire,
  • the questionnaire was completed by the patient themselves without the intervention of a caregiver (self-administration)
  • the fact that new care practices, aimed at humanising a stay in intensive care and making the experience of a stay in intensive care less traumatic, were described after the publication of the IPREA3 study a
  • a longer programme learning period of 9 months (compared to 5 months during the IPREA3 study)
  • the launch of the PREMREA programme with a conference led by a patient expert

Description

Hospitalisation in intensive care is always traumatic and can lead to a long rehabilitation process, slowed down by symptoms of anxiety and/or depression, and/or post-traumatic stress disorder (PTSD). These psychiatric disorders, or post-intensive care syndrome (PICS), can persist for several years after hospitalisation in intensive care and cause functional disability. They are associated with the use of psychotropic drugs and mental health services, and impair health-related quality of life.

This research is based on the hypothesis that the traumatic nature of intensive care hospitalisation can be reduced by implementing programmes to improve intensive care hospitalisation conditions, promoting changes in the practices of all healthcare professionals involved in intensive care.

IPREA3 study (Kalfon et al, 2017) demonstrated that implementation of a tailor-made, multi-component programme, led by a doctor/non-medical caregiver duo and based on:

  1. a systematic assessment by the caregiver in charge of the patient on the day of discharge from intensive care of any discomfort experienced during the entire stay, based on a specific questionnaire (Inconforts des Patients de REAnimation - IPREA - comprising 16 items of discomfort (Kalfon et al, 2010),
  2. immediate feedback to caregivers with reminders of simple predetermined measures,
  3. monthly comparative feedback to promote a positive spirit of emulation among participating intensive care units, significantly reduced the overall discomfort score (derived from the IPREA questionnaire) perceived by patients hospitalised in an intensive care unit with sufficient experience in applying this programme, having used it for at least 5 months (Kalfon et al, 2017) .

The originality and interest of this research, in comparison with the IPREA3 study, lie in the following aspects:

  • the use of the most recent version of the IPREA questionnaire, which includes 18 discomfort items
  • the questionnaire was completed by the patient themselves without the intervention of a caregiver (self-administration) to avoid potential bias associated with the administration of the questionnaire by a caregiver from the unit in which the patient was hospitalised
  • the fact that new care practices, aimed at humanising a stay in intensive care and making the experience of a stay in intensive care less traumatic, were described after the publication of the IPREA3 study and then applied without assessing the impact on patient perception as measured using the IPREA questionnaire
  • a longer programme learning period of 9 months (compared to 5 months during the IPREA3 study) to allow healthcare teams to better assimilate the changes to care practices decided upon during monthly feedback sessions
  • the launch of the PREMREA programme with a conference led by a patient expert to raise awareness among intensive care teams

Eligibility

Inclusion Criteria:

  • Patient, male or female, aged ≥ 18 years
  • Patient discharged alive from intensive care
  • Patient hospitalised in intensive care for at least three calendar days
  • Patient affiliated with or beneficiary of a social security scheme
  • Patient who speaks French and has signed an informed consent form

Exclusion Criteria:

  • Patients whose situation is incompatible with completing the IPREA questionnaire
  • Protected patients: adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision
  • Patients hospitalised without consent
  • Pregnant and/or breastfeeding women

Study details
    PTSD - Post Traumatic Stress Disorder

NCT07525284

Almaviva Sante

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.